Gadamasetti K., Kolodziej S.A. (ed.) Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics

Springer Nature Switzerland AG, 2024. — 579 p. — ISBN: 978-3-031-62006-5This book outlines how advances in the diverse scientific and engineering disciplines of synthetic biology, DNA synthesis, production of protein therapeutics, and bioinformatics have led to the commercialization of new complex biotherapeutic modalities in modern era, including monoclonal and multi-specific antibodies, antibody drug conjugates (ADC), fusion proteins, CAR-T and CRISPR technologies and applications, mRNA vaccines and more. Enabling operations to bring these life-changing medicines into the hands of the needy patients include regulatory submissions to authorities across the globe, as well as streamlined production across manufacturing networks deemed necessary and are outlined in dedicated chapters. Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics captures the state of the art for many of these new modalities, offering innovative approaches to treat, prevent, and in some providential cases, cure the disease. This book will be of significant interest for many disciplines engaged jointly as teams convergently in delivering these medicines: bioprocess engineers, biologists, chemists, bioengineers, genetic engineers, healthcare professionals, regulatory bodies, among pharmaceutical industry professionals as well as in academic circles.Bioprocessing, Bioengineering and Process Chemistry in the Biopharmaceutical Industry: Using Chemistry and Bioengineering to Improve the Performance of Biologics
Synthetic Biology in Drug Development and Beyond
Increasing the Scalability of DNA Synthesis and Its Key Role in Expanding the Biopharmaceutical Discovery Process
Advancements in the Manufacture of Monoclonal Antibodies and Other Large Molecule Protein Therapeutics: Recent Innovations in Cell Culture Technology Enabling Process Intensification
Process Development and Manufacturing Considerations for Multispecific (Bispecific and Trispecific) Antibodies: Case Study
Metabolic and Process Engineering to Control Glycan Structures for Biopharmaceuticals Produced in Cultured Mammalian Cells
Even a Worm Will Turn: Immunity Following AAV Vector Administration
COVID-19 Vaccine Manufacturing Processes: Making the Molecules to Solve the Pandemic
CAR-T Bioprocessing
CRISPR Technology and Its Application in Therapeutics
Fusion Proteins: Current Status and Future Perspectives
Development of Antibody-Drug Conjugates
Mylotarg: The Journey to FDA Reapproval and Broad International Approval
Biopharmaceutical Informatics: A Strategic Vision for Discovering Developable Biotherapeutic Drug Candidates
Advanced Data Analytics Application in Biomanufacturing Processes
Overview of Complexities of Global CMC Regulatory Affairs
CMC Considerations for Continuous Bioprocess Design, Development, and Manufacturing
Three Decades of Advancements in Technical Transfer of Biologics: A Blueprint for Advanced Therapeutics
Emerging Biopharmaceutical Technologies and Trends